Genesis Healthcare, Inc. is a holding company, which engages in the provision of inpatient services through skilled nursing and assisted and senior living communites. It also offers rehabilitation and respiratory therapy services. It operates through the following segments: Inpatient, Rehabilitation Therapy, and Other Services. The Inpatient Services segment manages operation of skilled nursing facilities and assisted/senior living facilities. The Rehabilitation Therapy Services segment provides rehabilitation and respiratory therapy services. The Other Services segment comprises of other specialty medical services, including physician services, staffing services, and other healthcare related services. The company was founded on February 2, 2015 and is headquartered in Kennett Square, PA.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry Skilled nursing care facilities
Sub-IndustryN/A
SectorMedical
SymbolNYSE:GEN
CUSIPN/A
Phone610-444-6350
Debt
Debt-to-Equity Ratio-2.61
Current Ratio1.03
Quick Ratio1.03
Price-To-Earnings
Trailing P/E Ratio-0.72
Forward P/E Ratio-1.23
P/E GrowthN/A
Sales & Book Value
Annual Sales$5.37 billion
Price / Sales0.05
Cash Flow$2.50 per share
Price / Cash0.62
Book Value($10.54) per share
Price / Book-0.15
Profitability
EPS (Most Recent Fiscal Year)($2.11)
Net Income$-578,980,000.00
Net Margins-10.95%
Return on EquityN/A
Return on Assets-2.61%
Miscellaneous
Employees68,700
Outstanding Shares159,450,000
Market Cap$259.89 million
Genesis Healthcare (NYSE:GEN) Frequently Asked Questions
What is Genesis Healthcare's stock symbol?
Genesis Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "GEN."
How were Genesis Healthcare's earnings last quarter?
Genesis Healthcare Inc (NYSE:GEN) released its quarterly earnings results on Tuesday, August, 7th. The company reported ($0.39) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.26) by $0.13. The firm had revenue of $1.27 billion for the quarter, compared to analyst estimates of $1.31 billion. During the same quarter last year, the business earned ($0.70) earnings per share. View Genesis Healthcare's Earnings History.
When is Genesis Healthcare's next earnings date?
What price target have analysts set for GEN?
4 analysts have issued 12-month price objectives for Genesis Healthcare's stock. Their forecasts range from $2.00 to $7.00. On average, they expect Genesis Healthcare's share price to reach $3.25 in the next twelve months. This suggests a possible upside of 109.7% from the stock's current price. View Analyst Price Targets for Genesis Healthcare.
What is the consensus analysts' recommendation for Genesis Healthcare?
4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Genesis Healthcare in the last year. There are currently 3 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Genesis Healthcare.
Who are some of Genesis Healthcare's key competitors?
Some companies that are related to Genesis Healthcare include Apellis Pharmaceuticals (APLS), OraSure Technologies (OSUR), NeoGenomics (NEO), Radius Health (RDUS), Orthofix International (OFIX), Anthem (ANTX), Assembly Biosciences (ASMB), TG Therapeutics Inc common stock (TGTX), Avrobio (AVRO), Revance Therapeutics (RVNC), Cerus (CERS), Tricida (TCDA), National HealthCare (NHC), SurModics (SRDX) and Pharming Group (PHGUF).
Who are Genesis Healthcare's key executives?
Genesis Healthcare's management team includes the folowing people:
- George V. Hager, Chief Executive Officer & Director
- Paul D. Bach, Chief Operating Officer & Executive Vice President
- Thomas DiVittorio, Chief Financial Officer
- Richard L. Castor, Chief Information Officer & Senior Vice President
- Michael S. Sherman, Secretary, Senior Vice President & General Counsel
Has Genesis Healthcare been receiving favorable news coverage?
News stories about GEN stock have been trending positive recently, Accern Sentiment Analysis reports. The research firm scores the sentiment of media coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Genesis Healthcare earned a news and rumor sentiment score of 0.28 on Accern's scale. They also gave headlines about the company an impact score of 47.47 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the near future. View Recent Headlines for Genesis Healthcare.
Who are Genesis Healthcare's major shareholders?
Genesis Healthcare's stock is owned by a number of of retail and institutional investors. Top institutional investors include BlackRock Inc. (1.98%), Renaissance Technologies LLC (1.52%), Glassman Wealth Services (0.63%), Acadian Asset Management LLC (0.51%), Prescott Group Capital Management L.L.C. (0.39%) and EAM Investors LLC (0.21%). Company insiders that own Genesis Healthcare stock include Daniel Allen Hirschfeld, David A Reis, Joanne Susan Reifsnyder, Michael Scott Sherman, Paul David Bach, Stephen Scott Young and Thomas Divittorio. View Institutional Ownership Trends for Genesis Healthcare.
Which major investors are selling Genesis Healthcare stock?
GEN stock was sold by a variety of institutional investors in the last quarter, including Forward Management LLC and Glassman Wealth Services. Company insiders that have sold Genesis Healthcare company stock in the last year include David A Reis, Joanne Susan Reifsnyder, Michael Scott Sherman, Paul David Bach, Stephen Scott Young and Thomas Divittorio. View Insider Buying and Selling for Genesis Healthcare.
Which major investors are buying Genesis Healthcare stock?
GEN stock was purchased by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, BlackRock Inc., Acadian Asset Management LLC, EAM Investors LLC, Macquarie Group Ltd., Citadel Advisors LLC and Prescott Group Capital Management L.L.C.. View Insider Buying and Selling for Genesis Healthcare.
How do I buy shares of Genesis Healthcare?
Shares of GEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Genesis Healthcare's stock price today?
One share of GEN stock can currently be purchased for approximately $1.55.
How big of a company is Genesis Healthcare?
Genesis Healthcare has a market capitalization of $259.89 million and generates $5.37 billion in revenue each year. The company earns $-578,980,000.00 in net income (profit) each year or ($2.11) on an earnings per share basis. Genesis Healthcare employs 68,700 workers across the globe.
How can I contact Genesis Healthcare?
Genesis Healthcare's mailing address is 101 EAST STATE STREET, KENNETT SQUARE PA, 19348. The company can be reached via phone at 610-444-6350 or via email at [email protected]
MarketBeat Community Rating for Genesis Healthcare (NYSE GEN)
MarketBeat's community ratings are surveys of what our community members think about Genesis Healthcare and other stocks. Vote "Outperform" if you believe GEN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GEN will underperform the S&P 500 over the long term. You may vote once every thirty days.
